TY  - GEN
AU  - George,Goldy C
AU  - Barata,Pedro C
AU  - Campbell,Alicyn
AU  - Chen,Alice
AU  - Cortes,Jorge E
AU  - Hyman,David M
AU  - Jones,Lee
AU  - Karagiannis,Thomas
AU  - Klaar,Sigrid
AU  - Le-Rademacher,Jennifer G
AU  - LoRusso,Patricia
AU  - Mandrekar,Sumithra J
AU  - Merino,Diana M
AU  - Minasian,Lori M
AU  - Mitchell,Sandra A
AU  - Montez,Sandra
AU  - O'Connor,Daniel J
AU  - Pettit,Syril
AU  - Silk,Elaine
AU  - Sloan,Jeff A
AU  - Stewart,Mark
AU  - Takimoto,Chris H
AU  - Wong,Gilbert Y
AU  - Yap,Timothy A
AU  - Cleeland,Charles S
AU  - Hong,David S
TI  - Improving attribution of adverse events in oncology clinical trials
SN  - 1532-1967
PY  - 2019///0625
KW  - Adverse Drug Reaction Reporting Systems
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Clinical Trials, Phase III as Topic
KW  - methods
KW  - Drug Development
KW  - Humans
KW  - Randomized Controlled Trials as Topic
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.ctrv.2019.04.004
ER  -